Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 23, 2026 09:25 ET | Source: Umoja Biopharma, Inc.

Umoja Biopharma Appoints Dr. Marcela Maus and Dr. Athena Countouriotis to Board of Directors

SEATTLE, March 23, 2026 (GLOBE NEWSWIRE) -- Umoja Biopharma, Inc. (Umoja), a clinical-stage biotechnology company committed to delivering innovative and potentially curative immunotherapies for...
March 19, 2026 07:00 ET | Source: AC Immune SA

AC Immune Presents First In vivo Images of Brain TDP-43 Pathology from Phase 1 Trial of PET tracer ACI-19626, at AD/PDTM 2026

AC Immune Presents First In vivo Images of Brain TDP-43 Pathology from Phase 1 Trial of PET tracer ACI-19626, at AD/PDTM 2026 Initial data indicates significantly higher tracer uptake in patients...
September 30, 2025 07:55 ET | Source: Umoja Biopharma, Inc.

Umoja Biopharma Announces that UB-VV111 Receives FDA Fast Track Designation for Relapsed/Refractory B-Cell Malignancies

SEATTLE, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Umoja Biopharma, the clinical-stage leader of in vivo cell therapies that aim to realize the full reach and promise of CAR T cells, announced today that...
September 23, 2025 07:55 ET | Source: Umoja Biopharma, Inc.

Umoja Biopharma Named One of 2025’s Most Promising Biotech Companies by Endpoints News and Fierce Biotech

SEATTLE, Sept. 23, 2025 (GLOBE NEWSWIRE) -- Umoja Biopharma, the clinical-stage leader of in vivo cell therapies that aim to realize the full reach and promise of CAR T cells, today announced its...
January 27, 2025 08:05 ET | Source: Umoja Biopharma, Inc.

Umoja Biopharma Announces Appointment of Dr. Luke Walker as Chief Medical Officer

SEATTLE, Jan. 27, 2025 (GLOBE NEWSWIRE) -- Umoja Biopharma, Inc. (Umoja), the clinical-stage leader of in vivo cell therapies that aim to realize the full reach and promise of CAR T cells, today...
January 14, 2025 07:00 ET | Source: Umoja Biopharma, Inc.

Umoja Biopharma Announces Oversubscribed $100 Million Series C Financing to Advance In Vivo CAR T Pipeline through Key Oncology Clinical Milestones

Series C financing co-led by Double Point Ventures and DCVC Bio Proceeds to support the clinical development of VivoVec™ derived in vivo CAR T cells SEATTLE, Jan. 14, 2025 (GLOBE NEWSWIRE) --...
January 06, 2025 16:30 ET | Source: Umoja Biopharma, Inc.

Umoja Biopharma to Present at the 43rd Annual J.P. Morgan Healthcare Conference

SEATTLE, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Umoja Biopharma, Inc. (Umoja), the clinical-stage leader of in vivo cell therapies that aim to realize the full reach and promise of CAR T cells, today...
November 26, 2024 09:05 ET | Source: Umoja Biopharma, Inc.

Umoja Biopharma to Present at the 7th Annual Evercore ISI HealthCONx Conference

SEATTLE, Nov. 26, 2024 (GLOBE NEWSWIRE) -- Umoja Biopharma, Inc. (Umoja), the clinical-stage leader of in vivo and off-the-shelf cell therapies that aim to realize the full reach and promise of...
November 21, 2024 08:05 ET | Source: Umoja Biopharma, Inc.

Umoja Biopharma Appoints Scott Myers as Chairman of its Board of Directors

SEATTLE, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Umoja Biopharma, Inc. (Umoja), the clinical-stage leader of in vivo and off-the-shelf therapies that aim to realize the full reach and promise of CAR...
November 05, 2024 09:05 ET | Source: Umoja Biopharma, Inc.

Umoja Biopharma Announces Oral and Poster Presentations at the 66th American Society of Hematology Annual Meeting

SEATTLE, Nov. 05, 2024 (GLOBE NEWSWIRE) -- Umoja Biopharma, Inc. (Umoja), a transformative immunotherapy company creating off-the-shelf treatments that aim to extend the reach and effectiveness of...